This new blog gives an essential voice to the pharma market access and health outcomes dialogue.
Ponte Vedra Beach, Florida (PRWEB) February 26, 2013
While many healthcare policy and research blogs exist, only a handful focus solely on the pharma health economics, outcomes research, and market access community. The new blog, tHEORetically Speaking, fills a much-needed gap in the pharmaceutical industry, and is a natural extension of the HealthEconomics.Com, the top-rated Google website for news and resources for the HEOR, pricing and market access field.
The blog will provide topical news, insights and observations covering a variety of topics, including digital and social media as it relates to the pharma HEOR field, as well as healthcare reform, market access policy issues, and research design issues.
In an effort to provide a broad range of commentary and perspective from professionals throughout the industry, guest bloggers will be an important feature of tHEORetically Speaking. The first guest blogger is Nick Emptage, a health economist with extensive experience in both academic and private-sector health services research and technology evaluation, and the blogger behind healthycriticism.com. Mr. Emptage’s guest blog, entitled “Challenging a Sacred Cow: The Top-Down Approach to Comparative Effectiveness” explores the limitations of comparative effectiveness research (CER) as a basis for health policy decisions, and offers ways to address such limitations when designing optimal CER studies.
Future guest bloggers will cover topics contrasting pharmaceutical and healthcare pricing strategies with those of consumer goods, such as automobiles, as well as an investigation of the pros and cons of composite versus single endpoints in clinical trial and health outcomes trials.
Dr. Patti Peeples, President and Founder of HealthEconomics.Com and the new tHEORetically Speaking blog says, “This new blog adds an essential voice to the pharma market access and health outcomes dialogue. This will be a unique forum where issues associated with digital and social media for our health economics and outcomes research community will be evaluated. When establishing HealthEconomics.Com almost 20 years ago, we became pioneers in the online resource library for the HEOR community. We look forward to continuing that role as it related to the HEOR digital media arena.”
About HealthEconomics.Com (http://www.healtheconomics.com): A pioneer in the field, HealthEconomics.Com is the global authority in healthcare value and pharma market access. Each day, HealthEconomics.Com compiles the latest news, policy updates, resources, conferences, and jobs for BioPharma’s professionals involved in health economics, outcomes research, market access, and pricing. A trusted resource, HealthEconomics.Com’s comprehensive content is carefully selected by a discerning health economist editor, making it the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.
News Media interested in receiving the most current information on healthcare value and market access may obtain a free subscription to HealthEconomics.Com by visiting the site or by subscribing to the HealthEconomics.Com Newsletter.